Home > Healthcare > Medical Devices > Implantable Devices > Implantable Cardioverter Defibrillators Market

Implantable Cardioverter Defibrillators Market Share

  • Report ID: GMI7696
  • Published Date: Dec 2023
  • Report Format: PDF
 Download Free Sample

Implantable Cardioverter Defibrillators Market Share

The implantable cardioverter defibrillators industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Medtronic plc, BIOTRONIK SE & Co. KG, and Boston Scientific Corporation, among others have a notable presence in the market.
 

Implantable Cardioverter Defibrillators Market Companies

Some of the eminent market participants operating in the implantable cardioverter defibrillators industry include:

  • Abbott Laboratories
  • Medtronic plc
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • LivaNova plc
  • FUKUDA DENSHI CO. Ltd
  • IMRICOR MEDICAL SYSTEMS
  • Koninklijke Philips N.V
  • Nohen Kohden Corporation
  • CU Medical Germany GmbH
  • MEDIANA Co., Ltd.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for implantable cardioverter defibrillators surpassed USD 8.8 billion in 2023 and is projected to reach USD 15.9 billion by 2032 driven by the rising incidences of cardiovascular diseases, growing geriatric population, and continual technological advancements.

The biventricular devices segment held more than 42% share of the implantable cardioverter defibrillators industry in 2023 and is estimated to record substantial growth through 2032 owing to its increasing use among patients with heart failure and conduction abnormalities.

North America industry size for implantable cardioverter defibrillators was worth USD 4.7 billion in revenue in 2023 and is set to exhibit robust growth through 2032 driven by the ongoing adoption of state-of-the-art devices in the region.

Some of the leading implantable cardioverter defibrillator companies are Abbott Laboratories, Medtronic plc, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., CU Medical Germany GmbH, and MEDIANA Co., Ltd.

Implantable Cardioverter Defibrillators Market Scope

  • Implantable Cardioverter Defibrillators Market Size
  • Implantable Cardioverter Defibrillators Market Trends
  • Implantable Cardioverter Defibrillators Market Analysis
  • Implantable Cardioverter Defibrillators Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 12
    • Tables & Figures: 210
    • Countries covered: 22
    • Pages: 110
     Download Free Sample
    ×
    Get a free sample of Implantable Cardioverter Defibrillators Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.